Latest Insider Transactions at Bausch & Lomb Corp (BLCO)
This section provides a real-time view of insider transactions for Bausch & Lomb Corp (BLCO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bausch & Lomb Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bausch & Lomb Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2025
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+23.86%
|
-
|
|
May 27
2025
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+25.19%
|
-
|
|
May 27
2025
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+24.67%
|
-
|
|
May 27
2025
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+24.96%
|
-
|
|
May 27
2025
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+27.47%
|
-
|
|
May 27
2025
|
Karen Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+35.06%
|
-
|
|
May 27
2025
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+22.52%
|
-
|
|
May 27
2025
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+22.6%
|
-
|
|
May 27
2025
|
Gaoxiang Hu Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+24.96%
|
-
|
|
May 22
2025
|
Brent L Saunders CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+2.88%
|
-
|
|
May 22
2025
|
Brent L Saunders CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
22,000
+2.97%
|
$242,000
$11.28 P/Share
|
|
May 02
2025
|
Andrew C. Von Eschenbach Director |
BUY
Open market or private purchase
|
Direct |
1,695
+3.9%
|
$18,645
$11.76 P/Share
|
|
May 01
2025
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+3.66%
|
$20,757
$11.59 P/Share
|
|
May 01
2025
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,210
+4.72%
|
$24,310
$11.59 P/Share
|
|
Apr 24
2025
|
A Robert D Bailey EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,781
-5.42%
|
$127,153
$13.89 P/Share
|
|
Apr 24
2025
|
Andrew J. Stewart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,954
-5.91%
|
$51,402
$13.89 P/Share
|
|
Feb 28
2025
|
Luc Bonnefoy President,Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
4,139
-2.66%
|
$66,224
$16.0 P/Share
|
|
Feb 26
2025
|
Luc Bonnefoy President,Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
23,423
+22.98%
|
-
|
|
Feb 26
2025
|
Frederick Munsch SVP, Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
18,581
+20.67%
|
-
|
|
Feb 26
2025
|
Sam Eldessouky EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
59,459
+17.4%
|
-
|
|
Feb 26
2025
|
A Robert D Bailey EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,540
+18.35%
|
-
|
|
Feb 26
2025
|
Yehia Hashad EVP of R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
25,225
+17.42%
|
-
|
|
Feb 26
2025
|
Andrew J. Stewart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,423
+25.94%
|
-
|
|
Feb 26
2025
|
Brent L Saunders CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
168,168
+19.43%
|
-
|
|
Dec 23
2024
|
Andrew J. Stewart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,524
-5.49%
|
$42,908
$17.83 P/Share
|
|
Dec 23
2024
|
Yehia Hashad EVP of R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,075
-2.59%
|
$86,275
$17.83 P/Share
|
|
Dec 23
2024
|
Frederick Munsch SVP, Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,100
-2.81%
|
$52,700
$17.83 P/Share
|
|
Dec 23
2024
|
Brent L Saunders CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
98,431
-8.11%
|
$1,673,327
$17.83 P/Share
|
|
Dec 23
2024
|
A Robert D Bailey EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,402
-3.05%
|
$74,834
$17.83 P/Share
|
|
Dec 23
2024
|
Sam Eldessouky EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,831
-3.37%
|
$269,127
$17.83 P/Share
|
|
Sep 30
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,134
+2.27%
|
$21,546
$19.29 P/Share
|
|
Sep 30
2024
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,328
+2.95%
|
$25,232
$19.29 P/Share
|
|
Aug 05
2024
|
Brent L Saunders CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
32,250
+4.89%
|
-
|
|
Aug 05
2024
|
Brent L Saunders CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
32,250
+5.14%
|
$483,750
$15.66 P/Share
|
|
Aug 02
2024
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+25.75%
|
-
|
|
Aug 02
2024
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+26.84%
|
-
|
|
Aug 02
2024
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+26.84%
|
-
|
|
Aug 02
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+23.54%
|
-
|
|
Aug 02
2024
|
Karen Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+45.88%
|
-
|
|
Aug 02
2024
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+22.96%
|
-
|
|
Aug 02
2024
|
Gaoxiang Hu Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+26.48%
|
-
|
|
Aug 02
2024
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+26.48%
|
-
|
|
Aug 02
2024
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,696
+30.58%
|
-
|
|
Jul 25
2024
|
Luc Bonnefoy President,Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,144
-3.75%
|
$32,160
$15.53 P/Share
|
|
Jul 25
2024
|
Frederick Munsch SVP, Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,313
-2.3%
|
$19,695
$15.53 P/Share
|
|
Jul 25
2024
|
Sam Eldessouky EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,113
-2.1%
|
$76,695
$15.53 P/Share
|
|
Jul 25
2024
|
Yehia Hashad EVP of R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,841
-2.78%
|
$42,615
$15.53 P/Share
|
|
Jun 28
2024
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,764
+5.99%
|
$24,696
$14.52 P/Share
|
|
Jun 28
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,506
+4.36%
|
$21,084
$14.52 P/Share
|
|
Jun 14
2024
|
Luc Bonnefoy President,Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
958
-1.65%
|
$14,370
$15.09 P/Share
|